The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study.
Liao L, Tang J, Hong Z, Jiang W, Li Y, Kong L, Han K, Hou Z, Zhang C, Zhou C, Zhang L, Sui Q, Xiao B, Mei W, Yu J, Yang W, Pan Z, Ding PR.
Liao L, et al. Among authors: ding pr.
BMC Cancer. 2024 Feb 2;24(1):164. doi: 10.1186/s12885-024-11821-w.
BMC Cancer. 2024.
PMID: 38302968
Free PMC article.